OpenAI is taking its flagship generative AI product, ChatGPT, into the realm of advertising, a move that underscores the growing commercialization of artificial intelligence and raises questions about user experience and data ethics. As reported in the Tech Xplore article, “OpenAI testing ads in ChatGPT, with plans for broader rollout,” the company has begun testing…
Management consulting giant McKinsey & Company is testing the use of artificial intelligence in its graduate recruitment process, representing a significant shift in how top-tier professional services firms are leveraging emerging technologies to identify talent. As reported in the article “McKinsey tests AI chatbot in early stages of graduate recruitment” on Artificial Intelligence News, the…
OpenAI announced the launch of ChatGPT Translate, a move that positions the company to compete directly with the long-established Google Translate. As reported in the January 15 article “ChatGPT Translate is here to take on Google Translate” by StartupNews.fyi, the new service is designed to deliver more accurate and contextually nuanced translations across more than…
In a significant move to ensure responsible innovation in biomedical research, U.S. and European regulators have jointly established a set of guiding principles for artificial intelligence (AI) use in drug development. As reported in “US, European Regulators Set Principles for Good AI Practice in Drug Development” by Startup News FYI, the principles were released by…
In addressing the perennial challenge of high healthcare costs while ensuring quality patient care, an intriguing development has emerged in the intersection of healthcare and artificial intelligence. Israeli startup DiA Imaging Analysis has recently secured a remarkable sum of $40 million in a funding round led by the healthcare investment arm of the global electronics…
AstraZeneca has unveiled plans to significantly expand the role of artificial intelligence in its cancer research efforts, reflecting a broader shift within the pharmaceutical industry toward technology-driven drug discovery. As reported in “AstraZeneca bets on in-house AI to speed up oncology research” by Artificial Intelligence News, the British-Swedish pharmaceutical giant is investing heavily in building…
In a significant development in the autonomous vehicle industry, Tesla has announced its latest stride with the release of the Full Self-Driving (FSD) Beta software, marking a potentially pivotal advancement in the realm of self-driving cars. The news, recently covered in the article “Tesla releases Full Self-Driving Beta software in the U.S.,” by Calcalistech.com, heralds…
As we approach the close of the first half of 2026, the impact of vertical artificial intelligence (AI) technologies on various sectors is both profound and multifaceted. Originally highlighted in an article titled “Vertical AI in 2026: The Good, The Bad and The Ugly,” published by VC Cafe, the discourse surrounding these specialized AI applications…
Anthropic, the artificial intelligence company founded by former OpenAI researchers, has unveiled a specialized version of its Claude AI model tailored for the healthcare sector, in what could represent a significant shift in how generative AI is applied in clinical settings. As reported in the article “What is Claude for Healthcare? Anthropic Launches New AI…
The race for leveraging artificial intelligence in various industries has seen a significant push towards the development of autonomous vehicles, a sector that technology giants and automakers alike are keen to dominate. Among them, Mobileye, an Intel company renowned for its cutting-edge self-driving technologies, has recently unveiled its newest supercomputer, dubbed ‘EyeQ Ultra,’ dedicated to…
